In Alzheimer’s disease, where neurovascular dysfunction is a key early event, Endocan affects angiogenesis by interacting with VEGF and may also affect cerebral blood flow and oxygenation, which are critical for neuronal health. Here, VEGFA is linked to Alzheimer disease.